Poor Tolerability of rrRCC Treatment May Challenge Your Patients | AVEO Oncology
This site is intended for US healthcare professionals.
This site is intended for
US healthcare professionals.

After multiple prior treatments in renal cell carcinoma (RCC)
THE JOURNEY CAN QUICKLY BECOME A CHALLENGE



What would it take to change their journey ahead?

In rrRCC, the potential benefit of treatment may be hindered by poor tolerability;

if patients decline or cannot tolerate treatment, they do not have an opportunity to realize its potential benefits.